title: Anti-Tnf Biosimilars Indicated for Rheumatoid Arthritis are Increasingly Available in Europe: How Do Payers and Key Stakeholders Perceive Them?
authors.affiliation: Double Helix Consulting, London, UK.
authors.forename: N P S
authors.initials: NP
authors.lastname: Sewak
authors.affiliation: Double Helix Consulting, London, UK.
authors.forename: C
authors.initials: C
authors.lastname: Jones